Inhaled nitric oxide: Medical miracle or passing fad?

Respiratory Care

Volumn 43, Issue 11, 1998, Pages 978-987

  Dalton, Heidi J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Complications; Mechanical ventilation; Nitric oxide; Pediatric acute respiratory distress syndrome; Pulmonary hypertension

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; NITRIC OXIDE;

CARDIOVASCULAR AUTOREGULATION; CLINICAL TRIAL; CONGENITAL HEART DISEASE; HEART TRANSPLANTATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG EDEMA; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG INJURY; LUNG TRANSPLANTATION; NONHUMAN; OXYGEN TOXICITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; REVIEW;

EID: 0032431041     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288(5789):373-376.
2. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs (review). Annu Rev Pharmacol Toxicol 1984;24:175-197.
3. NIOSH recommendations for occupational safety and health standards 1988. MMWR Morb Mortal Wkly Rep 1988:Aug 26:37 Suppl 7:1-29.
4. Fourbert L, Fleming B, Latimer R, Jonas M, Oduro A, Borland C, Higenhottam T. Safety guidelines for use of nitric oxide (letter). Lancet 1992;339(8809):1615-1616
5. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitritc: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitritc and endothelium-derived relaxing factor is nitric oxide. In: Vanhjoutte PM, editor. Vasodilatation: vascular smooth muscle, peptides. autonomic nerves and endothelium. New York, Raven Press;1988:401-414.
6. Ignarro LJ, Byrns RE, Wood KS. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical In: Vanhjoutte PM, editor. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothehum. New York Raven Press:1988:427-436.
7. Ignarro LJ, Buga GM, Woods KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987:84(24): 9265-9269.
8. Moncada S, Radomski MW, Palmer RMJ. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function (review). Biochem Pharmacol 1988;37(13):2495-2501.
9. Palmer RMJ, Ferrige AG, Moncada S, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524-526.
10. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause, of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338(8776): 1173-1174.
11. Busse R, Fleming I, Schmi VB. Nitric oxide formation in the vascular wall: regulation and functional implications (review). Curr Top Microbiol Immunol 1995;196:7-18.
12. Moncada S, Palmer RMJ, Higgs EA. Nitrc oxide: physiology, pathophysiology. and pharmacology (review). Pharmacol Rev 1991:43(2): 109-142.
13. Higenbottam TW, Laude EA. Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension. Giles F Filley lecture (review). Chest 1998:114 (1 Suppl):72S-79S.
14. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83(6):2038-2047.
15. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24(4):982-988.
16. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78(3):427-435.
17. Zapol WM, Rimar S, Gills N, Marletta M, Bosken CHH Nitric oxide and the lung. Am J Respir Crit Care Med 1994;149(5):1375-1380.
18. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340(8823):819-820.
19. Rossaint R, Falke KF, Lapez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328(6):399-405.
20. Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87(2):447-453.
21. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure J Pediatr 1994;124(6):881-888
22. Gerlach H, Pappen D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993:19(8):443-449.
23. Gerlach H, Rossaim R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23(8):499-502.
24. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD Jr, Zapol WM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994; 80(4):761-770.
25. Mclntyre RC Jr, Moore FA, Moore EE, Piedalue F, Haenel JS, Fullerton DA. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma 1995;39(3):418-425.
26. Greenbaum R, Bay J, Hargreaves MD, Kain ML, Kelman GR, Nunn JF. et al. Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth 1967;39(5):393-404.
27. Freeman G, Crane SC, Furiosi NJ, Stephens RJ, Evans MJ, Moore WD. Covert reduction in venulatory surface in rats during prolonged exposure to subacute nitrogen dioxide. Am Rev Respir Dis 1972; 106(4):563-579.
28. Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utell MJ. Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis 1991:143(3); 522-527.
29. Shiel FO. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39(5):413-424.
30. Freeman B: Free radical chemistry of nitric oxide: looking at the dark side (review). Chest 1994;105(3 Suppl):79S-84S.
31. Azoulay E, Lachia L, Blayo MC, Pocidalo JJ. Methaemoglobinemia induced by nitric oxide in whole blood: quantitative relationship. Toxicol Eur Res 1978;1(1):7-12.
32. Wessel DL, Adatia I, Thompson JE, Hickey PR, Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994;22(6):930-938.
33. Cockrill BA. The use of nitric oxide in primary pulmonary hypertension (review.). Respir Care Clin N Am 1997;3(4):505-519.
34. Hess D, Ritz R, Branson RD. Delivery systems for inhaled nitric oxide (review). Respir Care Clin N Am 1997;3(3):371-410.
35. Body SC, Hartigan PM. Manufacture and measurement of nitrogen oxides (review). Respir Care Clin N Am 1997;3(3):411-434.
36. Wessel DL, Adatia I, Van Marter LJ, Thompson JE, Kane JW, Stark AR, Kourembanas S. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn Pediatrics 1997;100(5):E7.
37. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group N Engl J Med 1997:336(9):597-604.
38. Roberts JD JR, Fineman JR, Morin FC III. Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn, N Engl J Med 1997;326(9):605-610,
39. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics 1998;101(3 Pt 1): 325-334.
40. Demirakca S, Dotsch J, Knothe C, Magsaam J, Reiter HL, Bauer J, Kuehl PG. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome, dose response, prolonged inhalation, and weaning. Crit Care Med 1996;24(11):1913-1919.
41. Dalton HJ, Hertzog J, Hauser GH. Impact of inhaled nitric oxide (INO) on ECMO utilization and survival in severe respiratory failure (RF). Crit Care Med 1998;Suppl:A117.
42. Goldman AP, Taster RC, Hosiasson S, Henrichsen T, Macrae DJ. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure Chest 1997; 112(3):752-758.
43. Steinhart C, Timmons OD, Fackler J, Green T, Nichols D et al. Severe acute respiratory distress syndrome is uniformly fatal in pediatric patients with immune deficiency, chronic lung disease, myocardial failure or CNS injury. Pediatric Critical Care Colloquium, Milwaukee WI 1996:19.
44. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. The Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1):15-23.
45. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73(1): 65-68.
46. Berner M, Beghetti M, Ricou B, Rouge JG, Pretre R, Friedli B. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993;19(2):75-77.
47. Celermajer DS, Cullen S, Deanfield JE, Endothelial dysfunction occurs early in the pulmonary circulation of children with congenital heart disease. Circulation. 1992;86(suppl I):I-775
48. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Branner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69(19):1596-1601.
49. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994;107(4):1129-1135.
50. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88(5 Pt 1):2128-2138.
51. Rich GF, Murphy GD Jr, Roos CM, Johns RA. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993;78(6):1028-1035.
52. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, et al. Impaired endoihelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19(5):918-925.
53. Wheller J, George BL, Mulder DG, Jarmakani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979;60(7):1640-1644.
54. Heath D, Smith P, Gosney J, Mulcahy D, Fox K, Yacoub M, Harris P. The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J 1987;58(3):204-213.
55. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension results from a national prospective registry. Ann Intern Med 1991;115(5):343-349
56. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333(4):214-221.
57. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996;153(6 Pt 1):1773-1780.
58. Matsumoto A, Hirata Y, Momomura S, Fujita H, Yao A, Sata M, Serizawa T. Increased nitric oxide production during exercise (letter). Lancet 1994;343(8901):849-850.
59. Riley MS, Porszasz J, Miranda J. Engelen MP, Brundage B, Wasserman K. Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis. Chest 1997;111(1): 44-50.
60. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25(7):1656-1664.
61. Cockrill BA, Kacmarek RM, Thompson BT, et al. Response to inhaled nitric oxide identifies a subset of patients more likely to respond to high-dose calcium channel blockers (abstract). Am J Respir Crit Care Med 1995;151:728.
62. Roberts JD Jr, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995;76(2):215-222.
63. Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993;72(2):246-254.
64. Lee JS, Adrie C, Jacob HJ, Roberts JD Jr, Zapol WM, Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res 1996;78(2):337-342.
65. Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, Fackler JC, Wessler DL. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57(5):1311-1318.
66. Bacha EA, Herve P, Murakami S, Chapelier A, Mazmaman GM, de Montpreville V, et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg 1996;112(3):590-598.
67. Date H, Triantafillou AN, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111(5):913-919.
68. Myles PS, Venerna HR. Avoidance of cardiopulmonary bypass during bilateral sequential lung transplantation using inhaled nitric oxide. J Cardiothorac Vase Anesth 1995;9(5):571-574.
69. Pinsky DJ, Naka Y., Chowdhury NC, Liao H, Oz MC, Michler RE, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A 1994;91(25):12086-12090.
70. Koul B, Willen H, Sjoberg T, Wetterberg T, Kugelberg J, Steen S. Pulmonary sequelae of prolonged total venoarterial bypass; evaluation with a new experimental model. Ann Thorac Surg 1991;51(5): 794-799.
71. Auler JO Jr, Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, Jatene AD. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 1996;15(5):443-450.
72. Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 1995;151(4):1263-1266.
73. Loh E. Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90(6):2780-2785.
74. Pfeffer KD, Ellison G, Robertson D, Day RW. The effect of inhaled nitric oxide in pediatric asthma. Am J Respir Crit Care Med 1996; 153(2):747-751.
75. Murphy S, Minor RL Jr, Welk G, Harrison DG. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem 1990;55(1):349-351.
76. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148(3):1482-1489.
77. Vidal MJ, Romero, JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 1988;149(3): 401-402.